CLVR RSI Chart
Last 7 days
38.1%
Last 30 days
5.5%
Last 90 days
110.1%
Trailing 12 Months
1293.9%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 16.7M | 17.6M | 18.6M | 0 |
2022 | 16.9M | 17.4M | 16.2M | 17.8M |
2021 | 26.5M | 28.2M | 28.3M | 15.4M |
2020 | 12.3M | 16.9M | 21.4M | 25.9M |
2019 | 0 | 0 | 0 | 7.8M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 08, 2024 | hague henry r iii | sold | -562 | 3.3108 | -170 | chief financial officer |
Feb 27, 2024 | hague henry r iii | sold | -1,623 | 3.95 | -411 | chief financial officer |
Jan 19, 2024 | fajardo andres | sold | -4,501 | 2.884 | -1,561 | chief executive officer |
Jan 19, 2024 | wilches julian | sold | -377 | 2.884 | -131 | chief regulatory officer |
Dec 20, 2023 | fajardo andres | sold | -360 | 2.0367 | -177 | chief executive officer |
Dec 20, 2023 | wilches julian | sold | -274 | 2.0367 | -135 | chief regulatory officer |
Jul 18, 2023 | hague henry r iii | sold | -335 | 0.2152 | -1,560 | chief financial officer |
Jul 18, 2023 | wilches julian | sold | -174 | 0.2152 | -813 | chief regulatory officer |
Which funds bought or sold CLVR recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Mar 11, 2024 | VANGUARD GROUP INC | added | 2.85 | -19,067 | 31,700 | -% |
Feb 14, 2024 | AMUNDI | unchanged | - | 5,825 | 29,547 | -% |
Feb 14, 2024 | Royal Bank of Canada | new | - | - | - | -% |
Feb 14, 2024 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | sold off | -100 | -388 | - | -% |
Feb 14, 2024 | TWO SIGMA SECURITIES, LLC | reduced | -24.03 | -118 | 438 | -% |
Feb 14, 2024 | Penserra Capital Management LLC | unchanged | - | -7,000 | 10,000 | -% |
Feb 14, 2024 | Davidson Kempner Capital Management LP | unchanged | - | -936 | 3,969 | -% |
Feb 14, 2024 | Walleye Capital LLC | unchanged | - | 273 | 8,062 | -% |
Feb 14, 2024 | Skaana Management L.P. | unchanged | - | 174 | 5,134 | -% |
Feb 13, 2024 | RENAISSANCE TECHNOLOGIES LLC | added | 20.54 | -26,000 | 72,000 | -% |
Unveiling Clever Leaves Holdings Inc.'s Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Clever Leaves Holdings Inc.)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
JNJ | 380.6B | 85.2B | 10.83 | 4.47 | ||||
MRK | 333.8B | 60.1B | 914.53 | 5.55 | ||||
PFE | 156.9B | 46.5B | -113.02 | 3.37 | ||||
AMGN | 153.4B | 28.2B | 22.84 | 5.44 | ||||
GILD | 91.0B | 27.1B | 16.06 | 3.35 | ||||
TEVA | 16.2B | 15.8B | -28.08 | 1.02 | ||||
MID-CAP | ||||||||
ALKS | 4.6B | 1.7B | 12.8 | 2.74 | ||||
PRGO | 4.3B | 4.7B | -335.7 | 0.92 | ||||
BHC | 3.8B | 8.8B | -6.47 | 0.44 | ||||
AMPH | 2.1B | 644.4M | 15.22 | 3.25 | ||||
SMALL-CAP | ||||||||
TLRY | 1.8B | 700.5M | -1.29 | 2.63 | ||||
TXMD | 24.2M | 70.0M | 0.35 | 0.34 | ||||
ACRX | 18.7M | - | -1.01 | 0.22 | ||||
ACOR | 14.8M | 111.1M | -0.93 | 0.13 | ||||
AGRX | 929.3K | 20.0M | -0.07 | 0.05 |
Clever Leaves Holdings Inc. News
Income Statement (Quarterly) | |||||||||||||||||
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 |
Revenue | -23.3% | 3,820,000 | 4,981,000 | 3,978,000 | 5,792,000 | 2,867,000 | 4,100,000 | 5,041,000 | 4,194,000 | 4,031,000 | 3,672,000 | 3,477,000 | 17,121,000 | 3,917,000 | 1,939,000 | 2,914,000 | - |
Gross Profit | -28.8% | 1,942,000 | 2,726,000 | 2,234,000 | -2,043,000 | 1,299,000 | 2,481,000 | 2,593,000 | 970,000 | 1,931,000 | 1,768,000 | 2,140,000 | 2,272,000 | 2,073,000 | 907,000 | 2,161,000 | - |
Operating Expenses | -9.9% | 5,319,000 | 5,901,000 | 6,364,000 | 33,667,500 | 25,623,000 | 7,829,000 | 12,312,000 | 31,122,000 | 11,615,000 | 11,371,000 | 9,908,000 | 9,590,000 | 6,784,000 | 8,232,000 | 11,335,000 | - |
S&GA Expenses | 24.1% | 582,000 | 469,000 | 549,000 | -178,000 | 615,000 | 728,000 | 732,000 | 1,879,000 | 208,000 | 241,000 | 587,000 | 285,000 | 508,000 | 603,000 | 1,181,000 | - |
R&D Expenses | -27.5% | 292,000 | 403,000 | 212,000 | 605,000 | 343,000 | 359,000 | 412,000 | 509,000 | 454,000 | 305,000 | 278,000 | - | - | - | - | - |
EBITDA Margin | 31.3% | -2.53 | -3.68 | -3.56 | -3.88 | -3.47 | -1.75 | -2.42 | -2.65 | -0.70 | -0.95 | -1.01 | -0.90 | -1.98 | -2.51 | -3.42 | -5.40 |
Interest Expenses | - | - | - | - | -516,000 | - | - | 375,000 | 117,000 | - | - | 548,000 | -65,000 | - | - | - | - |
Income Taxes | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Earnings Before Taxes | -123.0% | -7,271,000 | -3,261,000 | -4,151,000 | -35,709,000 | -24,841,000 | 1,856,000 | -13,761,000 | -22,994,000 | 1,009,000 | -8,942,000 | -13,754,000 | -846,000 | -6,106,000 | -8,748,000 | -10,175,000 | - |
EBT Margin | 29.7% | -2.71 | -3.86 | -3.75 | -4.07 | -3.69 | -1.95 | -2.64 | -2.91 | -0.80 | -1.05 | -1.11 | -1.00 | -2.15 | -2.72 | -3.72 | -5.86 |
Net Income | -42.9% | -5,138,000 | -3,595,000 | -4,081,000 | -28,816,000 | -20,163,000 | -1,046,000 | -16,140,000 | -24,000,000 | 995,000 | -8,956,000 | -13,765,000 | -2,686,000 | -5,094,000 | -8,753,000 | -10,186,000 | - |
Net Income Margin | 30.3% | -2.24 | -3.22 | -3.23 | -3.72 | -3.79 | -2.31 | -2.84 | -2.97 | -0.86 | -1.08 | -1.15 | -1.03 | -1.85 | -2.34 | -3.20 | -5.05 |
Free Cashflow | -33.4% | -2,309,000 | -1,731,000 | -6,112,000 | -4,547,000 | -5,640,000 | -8,599,000 | -11,586,000 | -9,370,000 | -10,328,000 | -10,972,000 | -12,843,000 | -4,061,000 | -3,586,000 | -9,103,000 | -8,876,000 | - |
Balance Sheet | ||||||||||||||
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2019Q4 |
Assets | -11.8% | 38.00 | 43.00 | 46.00 | 52.00 | 81.00 | 105 | 127 | 116 | 141 | 150 | 159 | 166 | 96.00 |
Current Assets | -2.6% | 18.00 | 18.00 | 21.00 | 26.00 | 41.00 | 44.00 | 69.00 | 60.00 | 68.00 | 77.00 | 87.00 | 96.00 | 24.00 |
Cash Equivalents | 27.5% | 6.00 | 5.00 | 6.00 | 12.00 | 18.00 | 19.00 | 45.00 | 38.00 | 46.00 | 57.00 | 69.00 | 79.00 | 13.00 |
Inventory | 3.2% | 8.00 | 7.00 | 8.00 | 8.00 | 17.00 | 17.00 | 16.00 | 15.00 | 14.00 | 13.00 | 12.00 | 10.00 | 5.00 |
Net PPE | -2.6% | 13.00 | 13.00 | 13.00 | 14.00 | 29.00 | 30.00 | 30.00 | 31.00 | 30.00 | 29.00 | 27.00 | 26.00 | 24.00 |
Goodwill | - | - | - | - | - | - | - | - | - | 19.00 | 19.00 | 19.00 | 19.00 | 20.00 |
Liabilities | -8.9% | 8.00 | 9.00 | 9.00 | 12.00 | 12.00 | 21.00 | 45.00 | 43.00 | 53.00 | 71.00 | 74.00 | 71.00 | 46.00 |
Current Liabilities | -9.5% | 7.00 | 8.00 | 8.00 | 9.00 | 8.00 | 9.00 | 27.00 | 27.00 | 33.00 | 57.00 | 31.00 | 30.00 | 6.00 |
Long Term Debt | - | - | - | - | - | - | - | - | - | 6.00 | - | 27.00 | 7.00 | 27.00 |
Shareholder's Equity | -12.5% | 30.00 | 34.00 | 37.00 | 40.00 | 70.00 | 85.00 | 82.00 | 73.00 | 88.00 | 79.00 | 84.00 | 95.00 | 50.00 |
Retained Earnings | -2.7% | -193 | -188 | -184 | -180 | -152 | -131 | -130 | -114 | -90.74 | -91.73 | -82.78 | -69.01 | -31.93 |
Additional Paid-In Capital | 0.4% | 223 | 223 | 222 | 221 | 222 | 217 | 213 | 188 | 178 | 171 | 167 | 164 | 77.00 |
Accumulated Depreciation | 5.0% | 8.00 | 8.00 | 8.00 | 7.00 | 8.00 | 7.00 | 6.00 | 6.00 | 5.00 | 4.00 | 4.00 | 3.00 | 1.00 |
Shares Outstanding | 13.3% | 2.00 | 2.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 0.00 |
Cashflow (Quarterly) | |||||||||||||||||
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 |
Cashflow From Operations | -30.5% | -2,201 | -1,687 | -6,077 | -5,097 | -5,385 | -8,213 | -10,371 | -8,038 | -8,699 | -8,869 | -10,627 | -3,682 | -3,736 | -7,322 | -7,221 | - |
Share Based Compensation | -88.0% | 52.00 | 434 | 468 | -263 | 958 | 1,148 | 500 | 3,314 | 3,264 | 3,323 | 1,550 | 747 | 489 | -297 | 416 | - |
Cashflow From Investing | 6275.0% | 2,717 | -44.00 | -35.00 | 550 | -255 | 2,112 | -1,215 | -1,332 | -1,629 | -2,103 | -2,216 | -379 | 150 | -1,781 | -1,655 | - |
Cashflow From Financing | 360.6% | 760 | 165 | -107 | -250 | 3,886 | -19,038 | 18,691 | 883 | -585 | -1,097 | 2,633 | 77,206 | 3,653 | -5,987 | 16,966 | - |
Buy Backs | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 6,250 | - | - |
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) | 3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Income Statement [Abstract] | ||||
Revenue, net | $ 3,820,000 | $ 2,867,000 | $ 12,779,000 | $ 12,008,000 |
Cost of sales | (1,878,000) | (1,568,000) | (5,877,000) | (5,635,000) |
Gross profit | 1,942,000 | 1,299,000 | 6,902,000 | 6,373,000 |
Expenses | ||||
General and administrative | 4,155,000 | 5,442,000 | 14,327,000 | 18,865,000 |
Sales and marketing | 582,000 | 615,000 | 1,600,000 | 2,075,000 |
Research and development | 292,000 | 343,000 | 907,000 | 1,114,000 |
Restructuring expenses | 0 | (82,000) | 0 | 3,761,000 |
Goodwill impairment | 19,000,000 | 19,000,000 | ||
Depreciation and amortization | 290,000 | 305,000 | 750,000 | 950,000 |
Total expenses | 5,319,000 | 25,623,000 | 17,584,000 | 45,765,000 |
Loss from operations | (3,377,000) | (24,324,000) | (10,682,000) | (39,392,000) |
Other Expense (Income), net | ||||
Interest and amortization of debt issuance cost | 5,000 | (58,000) | 23,000 | 2,696,000 |
Gain on remeasurement of warrant liability | (60,000) | (196,000) | (5,000) | (2,009,000) |
Gain on investment | 0 | 0 | 0 | (6,851,000) |
Investment impairment | 3,705,000 | 0 | 3,705,000 | 0 |
Loss on debt extinguishment, net | 0 | 0 | 0 | 2,263,000 |
Foreign exchange loss | 275,000 | 669,000 | 297,000 | 1,144,000 |
Other (income) expense, net | (31,000) | 102,000 | (19,000) | 111,000 |
Total other expenses (income), net | 3,894,000 | 517,000 | 4,001,000 | (2,646,000) |
Loss before income taxes and equity investment loss | (7,271,000) | (24,841,000) | (14,683,000) | (36,746,000) |
Deferred income tax (recovery) | 0 | (6,650,000) | 0 | (6,650,000) |
Equity investment share of loss | 0 | 0 | 0 | 64,000 |
Loss from continuing operations | (7,271,000) | (18,191,000) | (14,683,000) | (30,160,000) |
Income (loss) from discontinued operations | 2,133,000 | (1,972,000) | 1,869,000 | (7,189,000) |
Net loss | $ (5,138,000) | $ (20,163,000) | $ (12,814,000) | $ (37,349,000) |
Net loss per share: | ||||
Basic from continuing operations (USD per share) | $ (4.60) | $ (12.93) | $ (9.70) | $ (24.70) |
Diluted from continuing operations (USD per share) | (4.60) | (12.93) | (9.70) | (24.70) |
Basic from discontinued operations (USD per share) | 1.35 | (1.41) | 1.23 | (5.90) |
Diluted from discontinued operations (USD per share) | 1.35 | (1.41) | 1.23 | (5.90) |
Net loss per share - basic (USD per share) | (3.25) | (14.33) | (8.47) | (30.59) |
Net loss per share - diluted (USD per share) | $ (3.25) | $ (14.33) | $ (8.47) | $ (30.59) |
Weighted-average common shares outstanding - basic (in shares) | 1,580,456 | 1,407,419 | 1,513,575 | 1,221,107 |
Weighted-average common shares outstanding - diluted (in shares) | 1,580,456 | 1,407,419 | 1,513,575 | 1,221,107 |
Weighted-average common shares outstanding per share, basic (USD per share) | $ (3.25) | $ (14.33) | $ (8.47) | $ (30.59) |
Weighted-average common shares outstanding per share, diluted (USD per share) | $ (3.25) | $ (14.33) | $ (8.47) | $ (30.59) |
Condensed Consolidated Statements of Financial Position - USD ($) $ in Thousands | Sep. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current: | ||
Cash and cash equivalents | $ 6,472 | $ 12,449 |
Restricted cash | 66 | 439 |
Accounts receivable, net | 1,746 | 2,252 |
Prepaids, deposits and other receivables | 1,941 | 2,708 |
Inventories, net | 7,709 | 8,399 |
Total current assets | 17,934 | 26,247 |
Investment – Cansativa | 1,896 | 5,679 |
Property, plant and equipment, net of accumulated depreciation of $8,389 and $7,120 for September 30, 2023 and December 31, 2022, respectively | 12,752 | 13,963 |
Assets held for sale - Land | 1,500 | 1,500 |
Intangible assets, net | 2,821 | 3,354 |
Operating lease right-of-use assets, net | 820 | 1,303 |
Other non-current assets | 54 | 52 |
Total Assets | 37,777 | 52,098 |
Current: | ||
Accounts payable | 2,088 | 2,299 |
Accrued expenses and other current liabilities | 3,225 | 4,238 |
Loans and borrowings, current portion | 477 | 465 |
Warrant liability | 108 | 113 |
Operating lease liabilities, current portion | 512 | 1,239 |
Deferred revenue | 437 | 1,072 |
Total current liabilities | 6,847 | 9,426 |
Loans and borrowing — long-term | 859 | 1,065 |
Operating lease liabilities — long-term | 366 | 1,087 |
Other long-term liabilities | 16 | 112 |
Total Liabilities | 8,088 | 11,690 |
Contingencies and commitments | ||
Shareholders’ equity | ||
Preferred shares, without par value, unlimited shares authorized, nil shares issued and outstanding for each of September 30, 2023 and December 31, 2022 | 0 | 0 |
Common shares, without par value, unlimited shares authorized: 1,726,145 and 1,454,559 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively | 0 | 0 |
Additional paid-in capital | 223,407 | 221,313 |
Accumulated deficit | (193,718) | (180,905) |
Total shareholders' equity | 29,689 | 40,408 |
Total liabilities and shareholders' equity | $ 37,777 | $ 52,098 |